Home / Explore Insights / Letter to the Editor reply to Antonucci et al. Effect of hepatitis C genotype on CD4+ t cell count in a cohort of antiretroviral-naive HIV-1 infected individuals.

/ Insights / Explore Insights / Letter To The Editor Reply To Antonucci Et Al Effect Of Hepatitis C Genotype On Cd4 T Cell Count In A Cohort Of Antiretroviral Naive Hiv 1 Infected Individuals

Publications

Letter to the Editor reply to Antonucci et al. Effect of hepatitis C genotype on CD4+ t cell count in a cohort of antiretroviral-naive HIV-1 infected individuals.

December 31, 2004

Daar ES, Yoo TW, Lail A, Lynn HS, Donfield S
Journal of Infectious Diseases
HGDS
12/31/2004
Publication

Related insights

Successful Pediatric Investigation Plan (PIP) Application in the European Union – Part 1: Understanding the regulatory requirements

Regulation (EC) No 1901/2006 (the “Pediatric Regulation”) introduced the obligation for Sponsors to apply for a pediatric

Blog

Publications

Letter to the Editor reply to Antonucci et al. Effect of hepatitis C genotype on CD4+ t cell count in a cohort of antiretroviral-naive HIV-1 infected individuals.

Related insights

Study Data Standardization Plan (SDSP) – What it is and why it’s needed?

Traceability: The Breadcrumb Trail of Clinical Trial Data

Maximizing the Use of Real-World Data (RWD): Beyond the Theory

Splitting SDTM Datasets Using a Data Cutoff for Submission

New Drug Applications – When is it ok to not submit data to FDA?

Successful Pediatric Investigation Plan (PIP) Application in the European Union – Part 1: Understanding the regulatory requirements

END-IN-MIND TRIAL DESIGN

EXPERTISE

CAPABILITIES

Rho US Headquarters

Rho European Headquarters

END IN MIND TRIAL DESIGN

EXPERTISE

CAPABILITIES

Rho US Headquarters

Rho European Headquarters